Hugh Alexander Ilyine
Founder at Profactor Pharma Ltd.
Profile
Hugh Alexander Ilyine is the founder of two companies.
He founded Profactor Pharma Ltd.
in 2009 and Destina Genomics Ltd.
in 2011, where he holds the title of Director and Chief Executive Officer & Executive Director, respectively.
Mr. Ilyine's former jobs include Chief Operating Officer positions at Sierra Leone Diamond Co. Ltd.
and Stem Cell Sciences Plc.
Hugh Alexander Ilyine active positions
Companies | Position | Start |
---|---|---|
Profactor Pharma Ltd.
Profactor Pharma Ltd. Pharmaceuticals: MajorHealth Technology ProFactor Pharma Ltd. develops and supplies recombinant blood factors for the treatment of haemophilia. The firm commercialise and supply recombinant blood factors for the treatment of haemophilia to a undersupplied world market, starting with recombinant human Factor VIII (rhFVIII). The company was founded by Richard John Cruse, Ian Garner, Bruce Vernon, Hugh Ilyine and John H. McVey in 2009 and is headquartered in Midlothian, the United Kingdom. | Founder | 2008-12-31 |
Destina Genomics Ltd.
Destina Genomics Ltd. BiotechnologyHealth Technology Destina Genomics Ltd. is engaged in development of molecular diagnostic products. Its products include pipeline assay kits and liverace. The company was founded by Hugh Llyine, Juan J. Diaz-Mochon and Mark Bradley in 2011 and is headquartered in Edinburgh, the United Kingdom. | Founder | 2010-12-31 |
Former positions of Hugh Alexander Ilyine
Companies | Position | End |
---|---|---|
Stem Cell Sciences Plc | Chief Operating Officer | 2009-04-06 |
Sierra Leone Diamond Co. Ltd. | Chief Operating Officer | 2007-08-16 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
Sierra Leone Diamond Co. Ltd. | Non-Energy Minerals |
Stem Cell Sciences Plc | Commercial Services |
Profactor Pharma Ltd.
Profactor Pharma Ltd. Pharmaceuticals: MajorHealth Technology ProFactor Pharma Ltd. develops and supplies recombinant blood factors for the treatment of haemophilia. The firm commercialise and supply recombinant blood factors for the treatment of haemophilia to a undersupplied world market, starting with recombinant human Factor VIII (rhFVIII). The company was founded by Richard John Cruse, Ian Garner, Bruce Vernon, Hugh Ilyine and John H. McVey in 2009 and is headquartered in Midlothian, the United Kingdom. | Health Technology |
Destina Genomics Ltd.
Destina Genomics Ltd. BiotechnologyHealth Technology Destina Genomics Ltd. is engaged in development of molecular diagnostic products. Its products include pipeline assay kits and liverace. The company was founded by Hugh Llyine, Juan J. Diaz-Mochon and Mark Bradley in 2011 and is headquartered in Edinburgh, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Hugh Alexander Ilyine